Open access
Jul 2026
Benchmarking AI/ML-Driven PTIm-mAb Across Eleven FDA-Approved Bispecific Antibodies: A Cross-Tool Validation Study
PTIm-mAb is a multi-objective, AI/ML-driven antibody design platform that jointly optimizes sequence liabilities, surface aggregation, charge balance, humanness, and predicted binding affinity, and recommends a bispecific architecture in a single workflow.
M. Addepalli, Mahesh Prattipati
· bioRxiv · 0 citations